![Brian McNamee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian McNamee
Voorzitter bij
CSL LIMITED
Vermogen: 9 M $ op 31-05-2026
Profiel
Dr. Brian A. McNamee, MD, is directeur bij Tarnagulla Ventures Pty Ltd. Hij zetelt in de Raad van Bestuur van Zenyth Therapeutics Ltd. Dr. McNamee was voorheen werkzaam als Onafhankelijk Bestuurder bij Gen-Probe, Inc., Chief Executive Officer, Executive Director & MD bij CSL Ltd., President bij ZLB Behring LLC, General Manager-Faulding Product Divisions bij FH Faulding & Co. Ltd., en Managing Director bij Pacific Biotechnology Ltd. Hij was ook lid van de raad van bestuur van Gen-Probe, Inc. en Peter Maccallum Cancer Foundation Ltd. Hij behaalde zijn doctorale graad aan de Universiteit van Melbourne en zijn doctorale graad aan de Universiteit van Melbourne.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CSL LIMITED 0,03% | 17-02-2026 | 127.628 ( 0,03% ) | 9 M $ | 31-05-2026 |
Actieve functies van Brian McNamee
| Bedrijven | Functie | Begin |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Directeur/Bestuurslid | - |
| CSL LIMITED | Voorzitter | 17-10-2018 |
Geoff Ogilvy Foundation | Voorzitter | 01-05-2021 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Voorzitter | - |
Eerdere bekende functies van Brian McNamee
| Bedrijven | Functie | Einde |
|---|---|---|
Genesis Care Pty Ltd.
 Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Voorzitter | 01-06-2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | President | 01-07-2013 |
| CSL LIMITED | President | 01-07-2013 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Directeur/Bestuurslid | 31-05-2007 |
Tarnagulla Ventures Pty Ltd.
 Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Opleiding van Brian McNamee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FH Faulding & Co. Ltd.
 FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Finance |
Geoff Ogilvy Foundation |
